The AFSUMB Consensus Statements and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound using Sonazoid

The first edition of the guidelines for the use of ultrasound contrast agents was published in 2004, dealing with liver applications. The second edition of the guidelines in 2008 reflected changes in the available contrast agents and updated the guidelines for the liver, as well as implementing some...

Full description

Saved in:
Bibliographic Details
Published in:Ultrasonography (Seoul, Korea) 2020, 39(3), , pp.191-220
Main Authors: Lee, Jae Young, Minami, Yasunori, Choi, Byung Ihn, Lee, Won Jae, Chou, Yi-Hong, Jeong, Woo Kyoung, Park, Mi-Suk, Kudo, Nobuki, Lee, Min Woo, Kamata, Ken, Iijima, Hiroko, Kim, So Yeon, Numata, Kazushi, Sugimoto, Katsutoshi, Maruyama, Hitoshi, Sumino, Yasukiyo, Ogawa, Chikara, Kitano, Masayuki, Joo, Ijin, Arita, Junichi, Liang, Ja-Der, Lin, Hsi-Ming, Nolsoe, Christian, Gilja, Odd Helge, Kudo, Masatoshi
Format: Article
Language:English
Subjects:
Biology
Bubbles
consensus
Contrast agents
contrast media
Gases
Guideline
liver
Magnetic resonance imaging
Medicine
Meetings
Molecular weight
pancreatobiliary
sonazoid
Ultrasonic imaging
ultrasonography
방사선과학
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The first edition of the guidelines for the use of ultrasound contrast agents was published in 2004, dealing with liver applications. The second edition of the guidelines in 2008 reflected changes in the available contrast agents and updated the guidelines for the liver, as well as implementing some nonliver applications. The third edition of the contrast-enhanced ultrasound (CEUS) guidelines was the joint World Federation for Ultrasound in Medicine and Biology-European Federation of Societies for Ultrasound in Medicine and Biology (WFUMB-EFSUMB) venture in conjunction with other regional US societies such as Asian Federation of Societies for Ultrasound in Medicine and Biology, resulting in a simultaneous duplicate on liver CEUS in the official journals of both WFUMB and EFSUMB in 2013. However, no guidelines were described mainly for Sonazoid due to limited clinical experience only in Japan and Korea. The new proposed consensus statements and recommendations provide general advice on the use of Sonazoid and are intended to create standard protocols for the use and administration of Sonazoid in hepatic and pancreatobiliary applications in Asian patients and to improve patient management.
ISSN:2288-5919
2288-5943
DOI:10.14366/usg.20057